Table 2.
Anthropometric measurements, body composition, and biochemical parameters of the patients before and after bariatric surgery.
| Variable | Preoperative | 3-month follow-up | 6-month follow-up |
|---|---|---|---|
| BMI (kg/m2) | 41 (37.7–45.3) | 32.6 (29.1–35.8)* | 29.5 (26.3–33.3)*# |
| Weight (kg) | 108.7 (98.5–120.4) | 87.1 (78.3–95.3)* | 80 (71–88.4)*# |
| Fat mass (kg) | 54.3 (47.4–61.4) | 39.4 (30.1–47)* | 29.2 (22.8–39.8)*# |
| Fat-free mass (kg) | 52.8 (48.9–62.8) | 49.5 (44.9–55.9)* | 47.1 (44.4–54.2)* |
| Fat mass (%) | 50.2 (48.9–52.9) | 43.9 (40.6–46.9)* | 37 (34.6–42.3)*# |
| Chol (mg/dL) | 195 (169.5–214.8) | 165 (143.8–184)* | 162 (135.5–184.5)* |
| TG (mg/dL) | 123 (88–170) | 94.5 (67.5–120.2)* | 84 (70–105.2)* |
| HDL (mg/dL) | 45.6 (38.1–56.7) | 40 (36.6–49.7)* | 43.6 (38.6–50.5) |
| LDL (mg/dL) | 112.8 (102.3–135.5) | 98.2 (82.4–118.8) | 100.3 (76–115.6)* |
| Apo A (mg/dL) | 142.5 (125.2–165.8) | 124.5 (117.2–147.2)* | 134.5 (126.8–147.2)# |
| Apo B (mg/dL) | 103.5 (88.5–112) | 85 (75.8–94)* | 80 (70–94.2)* |
| Glucose (mg/dL) | 82 (78.8–96.5) | 81 (74–84) | 79 (76.2–84) |
| Insulin (mU/L) | 15.9 (10.7–20.2) | 6.1 (4.9–8.3)* | 5.4 (4.7–7.4)* |
| HOMA-IR | 3.4 (1.8–4.5) | 1.3 (0.9–1.8)* | 1.1 (1–1.5)* |
| hs-CRP (mg/dL) | 0.7 (0.3–1.1) | 0.3 (0.1–0.6)* | 0.2 (0.1–0.3)* |
n = 32. Data summarized as median (IQR), Apo: Apolipoprotein, BMI: Body Mass Index, HDL-c: High Density Lipoprotein Cholesterol, HOMA-IR: Homeostatic Model Assessment for Insulin Resistance, IQR: Interquartile Range, LDL-c: Low Density Lipoprotein Cholesterol, hs-CRP: high sensitivity C-reactive protein,*p-value < 0.05 vs Preoperative, #p-value < 0.05 vs 3-month follow-up; Friedman test with post-hoc pairwise Nemenyi test.